Assessment of symptoms in COMET-ICE, a phase 2/3 study of sotrovimab for early treatment of non-hospitalized patients with COVID-19
Abstract Background The COMET-ICE trial demonstrated that sotrovimab clinically and statistically significantly reduces the risk of all-cause > 24-h hospitalization or death due to any cause among patients with COVID-19 at high risk of disease progression. Patient-reported outcomes are important...
Saved in:
Main Authors: | Sacha Satram (Author), Parima Ghafoori (Author), Carolina M. Reyes (Author), Tom J. H. Keeley (Author), Helen J. Birch (Author), Dimitra Brintziki (Author), Melissa Aldinger (Author), Elizabeth Alexander (Author), Amanda Lopuski (Author), Elias H. Sarkis (Author), Anil Gupta (Author), Adrienne E. Shapiro (Author), John H. Powers (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterizing health-related quality of life and identifying disease predictors among patients suspected of having long COVID: an analysis of COMET-ICE clinical trial data
by: Heather L. Gelhorn, et al.
Published: (2024) -
Population pharmacokinetics and exposure‐response analysis of a single dose of sotrovimab in the early treatment of patients with mild to moderate COVID‐19
by: Jennifer E. Sager, et al.
Published: (2023) -
In the Days of the Comet
by: Wells, H. G. (Herbert George), 1866-1946 -
Spawn of the Comet
by: Rich, H. Thompson (Harold Thompson), 1893-1974 -
Comet Lore: Halley's Comet in History and Astronomy
by: Emerson, Edwin, 1869-1959